- Names Dan Twibell Chief Client Development Officer
SOMERSET, N.J., Nov. 9 /PRNewswire-FirstCall/ -- inVentiv Health Inc. (Nasdaq: VTIV) today announced that it has created a new Client Development and Integration team. The team will be led by Dan Twibell, who was recently promoted to Chief Client Development Officer.
The Client Development and Integration team will be responsible for working across the company's segments to identify new opportunities to serve both new and existing clients and to build broad, multidisciplinary solutions to meet their needs. The team also will develop tools and resources to support collaborative work across the entire enterprise.
"As the environment for developing, launching and selling healthcare products grows more complex, our clients are increasingly turning to us for help in designing innovative solutions to address their challenges," said Blane Walter, President of inVentiv Health. "Our vast range of expertise gives inVentiv the unique ability to develop broader, more insightful perspectives on the issues our clients are facing and then design multi- faceted programs to help them achieve their goals. Our new Client Development and Integration team will lead these efforts and will be a resource to support collaboration and integration across our business segments."
Dan Twibell, who leads the team, previously served as Executive Vice President at CHS, an inVentiv Health company that provides outsourced marketing and commercialization solutions for healthcare clients. During his nine-year tenure with inVentiv (including seven years with inChord Communications prior to its acquisition by inVentiv), Mr. Twibell directed dozens of multidisciplinary initiatives for clients and led numerous integrated new business efforts. Before inVentiv, Mr. Twibell worked in business development and marketing at Larreacorp and Eli Lilly and Company.
"Dan brings tremendous experience in bringing together leaders of different disciplines to create customized solutions for the healthcare industry. In his new position, he will play a critical role in advancing inVentiv's efforts to integrate our services on behalf of our clients," added Mr. Walter.
About inVentiv Health
inVentiv Health, Inc. (Nasdaq: VTIV) is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 250 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit http://www.inventivhealth.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
|SOURCE inVentiv Health Inc.|
Copyright©2007 PR Newswire.
All rights reserved